...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Embargo

Nextblockbuster,

Although the late breaking abstract embargo is lifted this afternoon and we will see the abstract today, the abstract presentation is not until Monday April 3rd. If there is any news release from Zenith, I would expect it on the day of presentation (Monday), and not today, in my opinion.

Keep in mind that published abstracts don't always contain the full amount of information shared at the actual presentation. Much time has passed since the abstract was submitted to AACR. On the other hand, quite often the info relayed in a presentation is exactly the same as in the abstract. So, we'll just have to let Monday happen and see. The late breaking abstract presentation is slated for the 8AM to 12 PM time slot (20 presentations total, including the one from Zenith). 

BDAZ

Share
New Message
Please login to post a reply